FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to pharmaceutical formulation applied for metastasis prevention and increasing of malignant hormone-dependant tissue tumour sensitisation to chemotherapeutic agents. Proposed oral pharmaceutical composition contains as active agents indole-3-carbinole, epigallocatechine-3-gallate and mineral premix including copper sulphate or gluconate, potassium or sodium iodide, iron lactate, sodium selenite, zinc sulphate or oxide, manganese sulphate or carbonate taken at specified ratio.
EFFECT: prevention of metastasis accompanying malignant tumour and increasing of tumour sensitisation to chemotherapeutic agents.
3 cl, 5 ex, 3 dwg
Authors
Dates
2008-07-10—Published
2007-04-23—Filed